// App-Quantinova.ai

511 : Objective sleep duration (SD) and overall survival (OS) in patients (pts) with metastatic colorectal cancer (MCC).

Researchers

Presenter

  • David Spiegel

Principal Investigators

  • Francis Levi

  • Georg A. Bjarnason

  • Ayhan Ulusakarya

  • Oxana Palesh

  • Pasquale F. Innominato

Medical Centers

  • Stanford School of Medicine, Stanford, CA

  • Hopital Paul Brousse, Villejuif, France

  • Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada

  • Paul Brousse Hospital, Villejuif, France

  • Warwick Medical School, Coventry, United Kingdom

Locations

  • United States

  • France

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Oxaliplatin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A